upadacitinib,tofacitinib,baricitinib
abbvie,pfizer,eli lilly
['tofa', ' upa ']
moa qu in gca: is one jaki better?
lab in tofa
proof-of-concept in bari
clinical trial in upa : unclear if any diff clinically gm-csf vs il-17?
maria cid: lots of redundancy in immune system
blocking one pathway, escalation of another?
we will see #acr22 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes podcast host for @austprescriber and others. All opinions my own